best performing chinese stocks 2004 to 2024

Mesoblast (MESO) had the highest return between 2004 and 2024 by a US stock, returning 19,799,900%.

ASSETYEARS% RETURN
Mesoblast (MESO)
2004-2024
19,799,900%
QXO (QXO)
2004-2024
7,949,900%
Fractyl Health, Inc Common Stock (GUTS)
2004-2024
3,531,328.57%
Avita Medical (RCEL)
2004-2024
3,199,900%
OPTIMIZERx (OPRX)
2004-2024
2,429,900%
Northern Oil & Gas (NOG)
2004-2024
1,365,837.5%
ACCESS Newswire (ACCS)
2004-2024
993,233.33%
Scienture (SCNX)
2004-2024
759,950.25%
Lunai Bioworks (LNAI)
2004-2024
711,389.36%
Lexaria Bioscience (LEXX)
2004-2024
470,049.25%
CleanSpark (CLSK)
2004-2024
460,400%
Addex Therapeutics (ADXN)
2004-2024
388,788.89%
LiveOne (LVO)
2004-2024
293,900%
Evogene (EVGN)
2004-2024
267,042.86%
MDxHealth (MDXH)
2004-2024
263,233.33%
Xcel Brands (XELB)
2004-2024
257,400%
Fubotv  (FUBO)
2004-2024
251,900%
Altimmune (ALT)
2004-2024
248,520.69%
Akari Therapeutics (AKTX)
2004-2024
195,100%
A2Z Smart Technologies (AZ)
2004-2024
178,818.92%
Integra Resources (ITRG)
2004-2024
173,900%
Immatics (IMTX)
2004-2024
142,100%
Cenntro Electric (CENN)
2004-2024
140,074.67%
Universal Insurance (UVE)
2004-2024
122,817.58%
Oramed Pharmaceuticals (ORMP)
2004-2024
77,693.1%